MammaGram
www.mammacare.com

Dear Ms. Kropf,

This is to let you know that I have just reviewed the preliminary data from Poland with Dr. Tad Slubowski of the Amberheart Breast Cancer Foundation and early results are stunning. 

The Avon/Amberheart Polish team trained and validated proficient CBE skills in 130 female health professionals in approximately 48 hours.  One of several confirming outcomes is the finding that the trainees were able to manually detect the smallest primary breast lesions visualized on mammographic images without access to the images. 

The group results are especially dramatic considering  the team had to translate into Polish the rigorous MammaCare breast examination training and evaluation standards. These standards require trainees to demonstrate tactile skills sufficient to reliably detect 3mm breast lesions in tactually accurate breast models and to demonstrate highly proficient examinations on actual breast tissue. While they may have missed some sleep, the nurses did not miss breast lesions.

The data emerging from this study are valuable to other jurisdictions in Eastern Europe where mass screening is still a dream and in America where more than half of the breast cancers are first discovered by someone's fingers. MammaCare has participated in pilot projects in Europe and Asia but this ambitious program trained so many clinicians in such a short interval that it may well inaugurate an effective new cancer screening protocol for an entire nation.  

MammaCare scientists will closely follow the progress of this endeavor and will join other clinicians to review the emerging data via our site www.mammacare.com .  

I would like to convey our most sincere congratulations for the scientific, medical and humanitarian achievements you and Avon Cosmetics of Poland have realized with this project...and for those yet to come!